Beijing Anzhen Hospital: Myocardial Infarction trials

The registry lists 12 Myocardial Infarction studies with Beijing Anzhen Hospital as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 4 3No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Angiography-Derived Physiological Indices for Outcome Prediction in Patients Undergoing OCT-Guided PCINot yet recruitingNCT07511231
• Coronary Imaging and Metabolic Indicators-Based Risk Prediction Model for Coronary Artery Disease(CMI-RiskCAD)Not yet recruitingNCT07353762
• Cardiac Magnetic Resonance - PROgnostic HEart Scar for Sudden Cardiac Death Prediction StudYRecruitingNCT07137936
• Treatment of ACuTe Coronary Syndromes With Low-dose colchICineRecruitingNCT06215989Not applicable
• Timing of Complete Revascularization in Patients With ST-segment Elevation Myocardial Infarction And Multivessel DiseaseStatus unknownNCT05231226Not applicable
• Randomized Evaluation of Shenfu Injection to Reduce Myocardial InjuryStatus unknownNCT04493840Phase 4
• ARomatherapy for Cognitive Trajectory in Chinese After Coronary Artery Bypass GraftingStatus unknownNCT04102696Not applicable
• Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCICompletedNCT03664180Phase 4
• CPAP for OSA on Myocardial Salvage After pPCI for STEMI PatientsStatus unknownNCT03444857Not applicable
• Study on High-sensitivity Troponin 0h/1h for Rapid Diagnosis of Non-ST-segment Elevation Myocardial Infarction in the Chinese PopulationStatus unknownNCT03331549
• ShenFu Injection for Myocardial Protection in Patients With Acute ST Segment Elevation Myocardial InfarctionCompletedNCT02709798Phase 4
• Impacts of Superselective Infarct-related Artery (IRA) Infusion of Tirofiban on Myocardial Reperfusion and Bleeding Complications in Acute Myocardial Infarction (AMI) PatientsStatus unknownNCT01181388Not applicable